Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanxu Zhang

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Clinical Drug Investigation|May 2, 2022
Effect of Genetic Polymorphism Including NUP153 and SVEP1 on the Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese SubjectsQian Xiang, Zhiyan Liu, Guangyan Mu, et al.
Pharmacotherapy|October 20, 2022
PROK2, HRNR, and FIG4 as potential genetic biomarkers of high bleeding propensity in East Asian patients with acute coronary syndrome using ticagrelorQian Xiang, Zhe Wang, Guangyan Mu, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 3, 2023
Identification of genetic biomarkers associated with pharmacokinetics and pharmacodynamics of apixaban in Chinese healthy volunteersGuangyan Mu, Qiufen Xie, Zhiyan Liu, et al.
Advanced Materials (Deerfield Beach, Fla.)|October 17, 2025
Ultrasensitive and Ultrafast Self-Powered Ultraviolet Photodetector Array for Solar-Blind and Weak-Light ImagingWeilong Deng, Xiangyu Fan, Yuxuan Du, et al.
Pharmacogenomics|May 14, 2020
<i>PNPT1</i> and <i>PCGF3</i> variants associated with angiotensin-converting enzyme inhibitor-induced cough: a nested case-control genome-wide studyGuangyan Mu, Qian Xiang, Zhuo Zhang, et al.
Current Pharmaceutical Design|October 25, 2024
Establishment of an Integrated Population Pharmacokinetic/ Pharmacodynamics Model of Apixaban in Chinese Healthy Population Adjusting for Key Genetic VariantsGuangyan Mu, Yaou Liu, Qiufen Xie, et al.
Cardiovascular Diagnosis and Therapy|November 23, 2020
Anti-FXa-IIa activity test in Asian and its potential role for drug adherence evaluation in patients with direct oral anticoagulants: a nationwide multi-center synchronization studyZhiyan Liu, Qiufen Xie, Qian Xiang, et al.
Clinical Therapeutics|March 29, 2024
The Pharmacogenetic Variability Associated with the Pharmacokinetics and Pharmacodynamics of Rivaroxaban in Healthy Chinese Subjects: A National Multicenter Exploratory StudyZhiyan Liu, Qiufen Xie, Xia Zhao, et al.
Clinical and Translational Medicine|December 1, 2022
Genetic variations in relation to bleeding and pharmacodynamics of dabigatran in Chinese patients with nonvalvular atrial fibrillation: A nationwide multicentre prospective cohort studyQian Xiang, Qiufen Xie, Zhiyan Liu, et al.
Clinical Pharmacokinetics|February 3, 2023
Integrated Pharmacokinetics/Pharmacodynamics Model and Simulation of the Ticagrelor Effect on Patients with Acute Coronary SyndromeZhiyan Liu, Yaou Liu, Guangyan Mu, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Clinical Drug Investigation|May 2, 2022
Effect of Genetic Polymorphism Including NUP153 and SVEP1 on the Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese SubjectsQian Xiang, Zhiyan Liu, Guangyan Mu, et al.
Pharmacotherapy|October 20, 2022
PROK2, HRNR, and FIG4 as potential genetic biomarkers of high bleeding propensity in East Asian patients with acute coronary syndrome using ticagrelorQian Xiang, Zhe Wang, Guangyan Mu, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 3, 2023
Identification of genetic biomarkers associated with pharmacokinetics and pharmacodynamics of apixaban in Chinese healthy volunteersGuangyan Mu, Qiufen Xie, Zhiyan Liu, et al.
Advanced Materials (Deerfield Beach, Fla.)|October 17, 2025
Ultrasensitive and Ultrafast Self-Powered Ultraviolet Photodetector Array for Solar-Blind and Weak-Light ImagingWeilong Deng, Xiangyu Fan, Yuxuan Du, et al.
Pharmacogenomics|May 14, 2020
<i>PNPT1</i> and <i>PCGF3</i> variants associated with angiotensin-converting enzyme inhibitor-induced cough: a nested case-control genome-wide studyGuangyan Mu, Qian Xiang, Zhuo Zhang, et al.
Current Pharmaceutical Design|October 25, 2024
Establishment of an Integrated Population Pharmacokinetic/ Pharmacodynamics Model of Apixaban in Chinese Healthy Population Adjusting for Key Genetic VariantsGuangyan Mu, Yaou Liu, Qiufen Xie, et al.
Cardiovascular Diagnosis and Therapy|November 23, 2020
Anti-FXa-IIa activity test in Asian and its potential role for drug adherence evaluation in patients with direct oral anticoagulants: a nationwide multi-center synchronization studyZhiyan Liu, Qiufen Xie, Qian Xiang, et al.
Clinical Therapeutics|March 29, 2024
The Pharmacogenetic Variability Associated with the Pharmacokinetics and Pharmacodynamics of Rivaroxaban in Healthy Chinese Subjects: A National Multicenter Exploratory StudyZhiyan Liu, Qiufen Xie, Xia Zhao, et al.
Clinical and Translational Medicine|December 1, 2022
Genetic variations in relation to bleeding and pharmacodynamics of dabigatran in Chinese patients with nonvalvular atrial fibrillation: A nationwide multicentre prospective cohort studyQian Xiang, Qiufen Xie, Zhiyan Liu, et al.
Clinical Pharmacokinetics|February 3, 2023
Integrated Pharmacokinetics/Pharmacodynamics Model and Simulation of the Ticagrelor Effect on Patients with Acute Coronary SyndromeZhiyan Liu, Yaou Liu, Guangyan Mu, et al.
Pageof 7